P

Piramal Pharma Ltd
NSE:PPLPHARMA

Watchlist Manager
Piramal Pharma Ltd
NSE:PPLPHARMA
Watchlist
Price: 226.72 INR 3.51% Market Closed
Market Cap: 299.4B INR

Intrinsic Value

The intrinsic value of one PPLPHARMA stock under the Base Case scenario is 142.76 INR. Compared to the current market price of 226.72 INR, Piramal Pharma Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PPLPHARMA Intrinsic Value
142.76 INR
Overvaluation 37%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Piramal Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PPLPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PPLPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Piramal Pharma Ltd
NSE:PPLPHARMA
IN
Pharmaceuticals
Market Cap
299.2B INR
IPO
Oct 19, 2022
IN
Pharmaceuticals
Market Cap
299.2B INR
IPO
Oct 19, 2022
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PPLPHARMA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Piramal Pharma Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Piramal Pharma Ltd

Balance Sheet Decomposition
Piramal Pharma Ltd

Current Assets 53.8B
Cash & Short-Term Investments 4.5B
Receivables 18.3B
Other Current Assets 31B
Non-Current Assets 98.6B
Long-Term Investments 2.5B
PP&E 49.2B
Intangibles 41.8B
Other Non-Current Assets 5.1B
Efficiency

Free Cash Flow Analysis
Piramal Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Piramal Pharma Ltd

Revenue
89.5B INR
Cost of Revenue
-32.9B INR
Gross Profit
56.6B INR
Operating Expenses
-45.4B INR
Operating Income
11.2B INR
Other Expenses
-10.8B INR
Net Income
389m INR
Fundamental Scores

PPLPHARMA Profitability Score
Profitability Due Diligence

Piramal Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive Operating Income
Positive Revenue Growth Forecast
51/100
Profitability
Score

Piramal Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

PPLPHARMA Solvency Score
Solvency Due Diligence

Piramal Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

Piramal Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PPLPHARMA Price Targets Summary
Piramal Pharma Ltd

Wall Street analysts forecast PPLPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 308.55 INR with a low forecast of 267.65 INR and a high forecast of 357 INR.

Lowest
Price Target
267.65 INR
18% Upside
Average
Price Target
308.55 INR
36% Upside
Highest
Price Target
357 INR
57% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PPLPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one PPLPHARMA stock?

The intrinsic value of one PPLPHARMA stock under the Base Case scenario is 142.76 INR.

Is PPLPHARMA stock undervalued or overvalued?

Compared to the current market price of 226.72 INR, Piramal Pharma Ltd is Overvalued by 37%.

Back to Top